Navigation Links
Oridion Announces Significant Medical Studies Presented at STA
Date:2/1/2009

identify forward-looking statements. These forward-looking statements involve known and unknown risks and uncertainties. Many factors could cause the actual results, performance or achievements of the Company to be materially different from any future results, performance or achievements that may be expressed or implied by such forward-looking statements, including, among others, our ability to maintain profits, the market demands for our Capnography products, our ability to focus our team on the Capnography business, changes in general economic and business conditions, inability to maintain market acceptance to the Company's products, inability to timely develop and introduce new technologies, products and applications, rapid changes in the market for the Company's products, loss of market share and pressure on prices resulting from competition, introduction of competing products by other companies, inability to manage growth and expansion, loss of key OEM partners, inability to attract and retain qualified personnel, inability to protect the Company's proprietary technology.

Furthermore, this press release does not constitute an offer to sell or a solicitation of an offer to buy any securities. The Company's shares issued have not been, and will not be, registered under the US Securities Act of 1933, as amended (the "Securities Act"), or under any of the relevant Securities Laws of any state of the United States. The Company's shares may not be offered, sold or delivered, directly or indirectly, to, or for, the account of any US person (as defined in regulation S under the Securities Act) in or into the United States, or by use of the US mail, or by any means or instrumentality of United States interstate commerce, absent registration, or an exemption from registration under the Securities Act.

    For further Oridion information please contact
    Alan Adler, Chairman and Chief Executive Officer
    Walter Ta
'/>"/>
SOURCE Oridion Systems Ltd.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related medicine technology :

1. Oridion Announces Major Medical Research and Congress Presentations
2. ThermoGenesis Announces MXP Involvement in New Regenerative Medicine Initiatives
3. British Midlands University Announces Use of Gene Technology to Fight Lethal Hospital Acquired Infection
4. Synvista Therapeutics Announces Termination of Clinical Trials of Alagebrium and SYI-2074 and Provides Business Update
5. Savient Announces FDAs Advisory Panel to Review Pegloticase for Treatment-Failure Gout Patients
6. Impact Medical Solutions Announces Appointment of New Director and Corporate Update
7. Oncolytics Biotech Inc. Announces Start of Patient Enrolment in Translational Clinical Trial Investigating REOLYSIN(R) in Patients with Metastatic Colorectal Cancer
8. ISTA Pharmaceuticals Announces Positive Results for Phase IIb Study of Ecabet Sodium
9. Immunomedics Announces Preclinical Therapy Results of SN-38 Immunoconjugate for Colorectal Cancer
10. Modigene Announces Positive Results of Pilot Toxicity Study of Its Long-Acting Human Growth Hormone hGH-CTP
11. Kyowa Hakko Kirin Announces Development Policy for Anti-Parkinsons Disease Drug KW-6002 (Istradefylline)
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/22/2015)... Electrophysiologist Kevin Makati, M.D. with St. ... Boston, MA to speak about ... Society conference. These scientific sessions drew more than ... people and technology that propel their specialty forward. ... invasive cardiac operation that combines the expertise of ...
(Date:5/22/2015)... 2015 The North American dental lasers ... estimated to reach $90.7 million by 2019, at a CAGR ... the TOC of North America Dental Lasers Market for an ... various tables and figures. http://www.micromarketmonitor.com/market/north-america-dental-lasers-1771208223.html ... report.   Dental lasers are specifically used ...
(Date:5/22/2015)...  The U.S. Food and Drug Administration,s (FDA) ... biosimilar product approved in the United ... the contract manufacturing organization (CMO) industry, according to ... to the production of small-molecular drugs and lacks ... healthcare market research publisher,s report, Biopharmaceutical and ...
Breaking Medicine Technology:St. Joseph's Hospital Heart Institute Physician Presents at Heart Rhythm Society 2St. Joseph's Hospital Heart Institute Physician Presents at Heart Rhythm Society 3North America Dental Lasers Market is Expected to Reach $90.7 Million by 2019, at a CAGR of 9.2% From 2014 to 2019 2North America Dental Lasers Market is Expected to Reach $90.7 Million by 2019, at a CAGR of 9.2% From 2014 to 2019 3Kalorama: First FDA-Approved Biosimilar Brings Hope for CMO Growth 2Kalorama: First FDA-Approved Biosimilar Brings Hope for CMO Growth 3Kalorama: First FDA-Approved Biosimilar Brings Hope for CMO Growth 4
... Columbia Laboratories, Inc. (Nasdaq: CBRX ), ... today confirmed that the Advisory Committee for Reproductive Health ... is scheduled to review Columbia,s New Drug Application (NDA) ... of preterm birth in women with short uterine cervical ...
... Valeant Pharmaceuticals International, Inc. (NYSE: VRX ) ... been named to the role of Executive Vice President ... employment with Valeant, which is expected to be December ... Sachs where he was the chief operating officer for ...
Cached Medicine Technology:Columbia Laboratories and Watson Pharmaceuticals Confirm FDA Advisory Committee to Review Preterm Birth NDA 2Columbia Laboratories and Watson Pharmaceuticals Confirm FDA Advisory Committee to Review Preterm Birth NDA 3Columbia Laboratories and Watson Pharmaceuticals Confirm FDA Advisory Committee to Review Preterm Birth NDA 4Valeant Pharmaceuticals Appoints Howard B. Schiller as Chief Financial Officer 2Valeant Pharmaceuticals Appoints Howard B. Schiller as Chief Financial Officer 3
(Date:5/26/2015)... (PRWEB) May 26, 2015 Many ... added to TheCelebrityDresses.com's formal dress collections recently. Now, ... newly designed dresses, up to 70% off. The ... the world to save hundreds of dollars on ... well-known brand in red carpet fashion special occasion ...
(Date:5/26/2015)... U.S. Food and Drug Administration (FDA) ... are extensive and can be difficult to understand. ... device companies comply with FDA regulations, compiled a list ... FDA requirements. , 1. Start researching early. ... be a lengthy process depending on the classification of ...
(Date:5/26/2015)... (PRWEB) May 26, 2015 Carl W. ... Pinehurst Surgical Center in Pinehurst, N.C. have launched a ... surgery patients about chronic sinusitis and the benefits of ... can be used to determine if someone is a ... about symptoms and other factors that can contribute to ...
(Date:5/25/2015)... (PRWEB) May 26, 2015 The ... Hooker as a 2015-2016 inductee into its VIP Professional ... this prestigious distinction for leadership in dentistry. NAPW is ... boasting more than 700,000 members and over 200 operating ... into this exceptional group of professional women,” said NAPW ...
(Date:5/25/2015)... May 25, 2015 World Patent Marketing, ... announces the Hidee-Hose, an undergarment patent that allays women’s ... Global Women's Hosiery industry forecasts the market to reach ... and Creative Director of World Patent Marketing , ... steering ahead and is expected to maintain its lead. ...
Breaking Medicine News(10 mins):Health News:Cocktail Dresses Inspired by Celebrities on Sale at TheCelebrityDresses.com 2Health News:FDA Medical Device Regulations: Top 10 Tips for Marketing a Device in the USA 2Health News:FDA Medical Device Regulations: Top 10 Tips for Marketing a Device in the USA 3Health News:FDA Medical Device Regulations: Top 10 Tips for Marketing a Device in the USA 4Health News:Pinehurst Surgical Sinus Center Launches Pinehurst Balloon Sinuplasty Website 2Health News:National Association of Professional Women Inducts Dr. Laquinas Hooked, D.D.S. of General Dentist, Into its VIP Professional Woman of the Year Circle 2Health News:For The Courtesy Of Women's Health And Looks - World Patent Marketing Presents A New Undergarment Patent 2Health News:For The Courtesy Of Women's Health And Looks - World Patent Marketing Presents A New Undergarment Patent 3
... Singapore might be prosperous. But it is also draconian. Any presumed ... ,,As the owner of a commercial fishing pond in Pasir Ris ... for breeding mosquitoes. The area is dubbed the number one dengue ... of Wednesday. ,The National Environment Agency (NEA) believes ...
... that the combined use of two minimally invasive techniquesendobronchial ... the diagnosis of peripheral lung lesions has been shown ... does not compromise patients safety. ,Multimodality ... has pushed the diagnostic yield of flexible bronchoscopic procedures ...
... unemployed Argentine Jorge as, picking up a hammer, he goes ... of Madrid. ,Elsewhere in the same hotel, ... but the hotel manager doesn't bat an eyelid. ... the NH Hoteles chain hatched to kill two birds with ...
... from the National Cancer Institute identified Variations in two ... factor for developing lung cancer. The effect of ... that the inflammatory response is important in modulating the ... of the American Association for Cancer Research, is the ...
... found that a variation in two genes related to inflammation, ... ,The study was conducted by a team of researchers led ... University of Texas M. D. Anderson Cancer Center. ... related to inflammation between more than 1,500 lung cancer patients ...
... suicidal thoughts and behaviors appear to be associated ... medication prescriptions among children and adolescents covered by ... are frequently used to treat depression among children ... an increased risk of suicidal thinking and behavior ...
Cached Medicine News:Health News:Dengue Surge in Singapore, Man Prosecuted for Breeding Mosquitoes 2Health News:Combination of Bronchoscopic Techniques is Very Effective for Lung Lesions 2Health News:Smashing Times for Stressed Spaniards 2Health News:Gene Variation Increases the Risk of Lung Cancer 2Health News:Variation in Genes Related to Inflammation Increase Lung Cancer Risk 2Health News:Reduction in Antidepressant Leads to Suicidal Risks 2
... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...
... a national reference laboratory and a worldwide ... ARUP offers an extensive test menu of ... clinical and anatomic pathology. Owned by the ... more than half of the nation's university ...
... ARUP Laboratories is a national reference laboratory ... research and development. ARUP offers an extensive ... medical tests in clinical and anatomic pathology. ... Laboratories' clients include more than half of ...
... ARUP Laboratories is a national reference laboratory ... research and development. ARUP offers an extensive ... medical tests in clinical and anatomic pathology. ... Laboratories' clients include more than half of ...
Medicine Products: